Skip to main content
Top
Published in: BMC Nephrology 1/2013

Open Access 01-12-2013 | Case report

A case of myeloperoxidase anti-neutrophil cytoplasmic antibody (MPO-ANCA)-associated glomerulonephritis and concurrent membranous nephropathy

Authors: Michiko Shimada, Takeshi Fujita, Norio Nakamura, Ikuyo Narita, Yuko Shimaya, Reiichi Murakami, Hideaki Yamabe, Hiroshi Osawa, Ken Okumura

Published in: BMC Nephrology | Issue 1/2013

Login to get access

Abstract

Background

Myeloperoxidase anti-neutrophil cytoplasmic antibody-associated glomerulonephritis (MPO-ANCA-GN) and concurrent membranous nephropathy (MN) are very rare combination. Their causal relationship has been suggested, but not determined.

Case presentation

A 73-years-old male with 5-year history of proteinuria underwent an operation for his sigmoid colon cancer. Seven months later, he was referred to a nephrology division due to an exacerbating renal function and hypoalbuminemia. Laboratory examination revealed positive MPO-ANCA in the serum. A renal biopsy revealed a necrotizing extracapillary proliferative glomerulonephritis with crescents, demonstrating MPO-ANCA-GN. Whereas, immunofluorescent staining documented granular deposition of immumoglobulin (Ig) G and C3 along the capillary wall and electron microscopy showed subepithelial deposits in the glomerular basement membrane demonstrating MN. Immunofluorescent staining of IgG subclass showed positive IgG1, IgG2, negative IgG3 and weak positive IgG4 suggested the possibility of malignancy-associated MN.

Conclusion

Combination of MPO-ANCA-GN and MN are rare. Although the causal relationship has been suggested in some cases, we should consider all the possibilities including idiopathic MN and secondary MN associated with malignancy, drug use or infection.
Appendix
Available only for authorised users
Literature
1.
go back to reference Haas M, Eustace JA: Immune complex deposits in ANCA-associated crescentic glomerulonephritis: a study of 126 cases. Kidney Int. 2004, 65 (6): 2145-2152. 10.1111/j.1523-1755.2004.00632.x.CrossRefPubMed Haas M, Eustace JA: Immune complex deposits in ANCA-associated crescentic glomerulonephritis: a study of 126 cases. Kidney Int. 2004, 65 (6): 2145-2152. 10.1111/j.1523-1755.2004.00632.x.CrossRefPubMed
2.
go back to reference Nasr SH, Said SM, Valeri AM, Stokes MB, Masani NN, D’Agati VD, Markowitz GS: Membranous glomerulonephritis with ANCA-associated necrotizing and crescentic glomerulonephritis. Clin J Am Soc Nephrol. 2009, 4 (2): 299-308. 10.2215/CJN.04060808.CrossRefPubMedPubMedCentral Nasr SH, Said SM, Valeri AM, Stokes MB, Masani NN, D’Agati VD, Markowitz GS: Membranous glomerulonephritis with ANCA-associated necrotizing and crescentic glomerulonephritis. Clin J Am Soc Nephrol. 2009, 4 (2): 299-308. 10.2215/CJN.04060808.CrossRefPubMedPubMedCentral
3.
go back to reference Kanahara K, Yorioka N, Nakamura C, Kyuden Y, Ogata S, Taguchi T, Yamakido M: Myeloperoxidase-antineutrophil cytoplasmic antibody-associated glomerulonephritis with membranous nephropathy in remission. Intern Med. 1997, 36 (11): 841-846. 10.2169/internalmedicine.36.841.CrossRefPubMed Kanahara K, Yorioka N, Nakamura C, Kyuden Y, Ogata S, Taguchi T, Yamakido M: Myeloperoxidase-antineutrophil cytoplasmic antibody-associated glomerulonephritis with membranous nephropathy in remission. Intern Med. 1997, 36 (11): 841-846. 10.2169/internalmedicine.36.841.CrossRefPubMed
4.
go back to reference Dwyer KM, Agar JW, Hill PA, Murphy BF: Membranous nephropathy and anti-neutrophil cytoplasmic antibody-associated glomerulonephritis: a report of 2 cases. Clin Nephrol. 2001, 56 (5): 394-397.PubMed Dwyer KM, Agar JW, Hill PA, Murphy BF: Membranous nephropathy and anti-neutrophil cytoplasmic antibody-associated glomerulonephritis: a report of 2 cases. Clin Nephrol. 2001, 56 (5): 394-397.PubMed
5.
go back to reference Tse WY, Howie AJ, Adu D, Savage CO, Richards NT, Wheeler DC, Michael J: Association of vasculitic glomerulonephritis with membranous nephropathy: a report of 10 cases. Nephrol Dial Transplant. 1997, 12 (5): 1017-1027. 10.1093/ndt/12.5.1017.CrossRefPubMed Tse WY, Howie AJ, Adu D, Savage CO, Richards NT, Wheeler DC, Michael J: Association of vasculitic glomerulonephritis with membranous nephropathy: a report of 10 cases. Nephrol Dial Transplant. 1997, 12 (5): 1017-1027. 10.1093/ndt/12.5.1017.CrossRefPubMed
6.
go back to reference Suwabe T, Ubara Y, Tagami T, Sawa N, Hoshino J, Katori H, Takemoto F, Hara S, Aita K, Hara S: Membranous glomerulopathy induced by myeloperoxidase-anti-neutrophil cytoplasmic antibody-related crescentic glomerulonephritis. Intern Med. 2005, 44 (8): 853-858. 10.2169/internalmedicine.44.853.CrossRefPubMed Suwabe T, Ubara Y, Tagami T, Sawa N, Hoshino J, Katori H, Takemoto F, Hara S, Aita K, Hara S: Membranous glomerulopathy induced by myeloperoxidase-anti-neutrophil cytoplasmic antibody-related crescentic glomerulonephritis. Intern Med. 2005, 44 (8): 853-858. 10.2169/internalmedicine.44.853.CrossRefPubMed
7.
go back to reference Hanamura K, Tojo A, Kinugasa S, Asaba K, Onozato ML, Uozaki H, Fukayama M, Fujita T: Detection of myeloperoxidase in membranous nephropathy-like deposits in patients with anti-neutrophil cytoplasmic antibody-associated glomerulonephritis. Hum Pathol. 2011, 42 (5): 649-658. 10.1016/j.humpath.2010.08.020.CrossRefPubMed Hanamura K, Tojo A, Kinugasa S, Asaba K, Onozato ML, Uozaki H, Fukayama M, Fujita T: Detection of myeloperoxidase in membranous nephropathy-like deposits in patients with anti-neutrophil cytoplasmic antibody-associated glomerulonephritis. Hum Pathol. 2011, 42 (5): 649-658. 10.1016/j.humpath.2010.08.020.CrossRefPubMed
8.
go back to reference Segelmark M, Wieslander J: IgG subclasses of antineutrophil cytoplasm autoantibodies (ANCA). Nephrol Dial Transplant. 1993, 8 (8): 696-702.PubMed Segelmark M, Wieslander J: IgG subclasses of antineutrophil cytoplasm autoantibodies (ANCA). Nephrol Dial Transplant. 1993, 8 (8): 696-702.PubMed
9.
go back to reference Ohtani H, Wakui H, Komatsuda A, Okuyama S, Masai R, Maki N, Kigawa A, Sawada K, Imai H: Distribution of glomerular IgG subclass deposits in malignancy-associated membranous nephropathy. Nephrol Dial Transplant. 2004, 19 (3): 574-579. 10.1093/ndt/gfg616.CrossRefPubMed Ohtani H, Wakui H, Komatsuda A, Okuyama S, Masai R, Maki N, Kigawa A, Sawada K, Imai H: Distribution of glomerular IgG subclass deposits in malignancy-associated membranous nephropathy. Nephrol Dial Transplant. 2004, 19 (3): 574-579. 10.1093/ndt/gfg616.CrossRefPubMed
10.
go back to reference Beck LH, Bonegio RG, Lambeau G, Beck DM, Powell DW, Cummins TD, Klein JB, Salant DJ: M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. New Engl J Med. 2009, 361 (1): 11-21. 10.1056/NEJMoa0810457.CrossRefPubMedPubMedCentral Beck LH, Bonegio RG, Lambeau G, Beck DM, Powell DW, Cummins TD, Klein JB, Salant DJ: M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. New Engl J Med. 2009, 361 (1): 11-21. 10.1056/NEJMoa0810457.CrossRefPubMedPubMedCentral
Metadata
Title
A case of myeloperoxidase anti-neutrophil cytoplasmic antibody (MPO-ANCA)-associated glomerulonephritis and concurrent membranous nephropathy
Authors
Michiko Shimada
Takeshi Fujita
Norio Nakamura
Ikuyo Narita
Yuko Shimaya
Reiichi Murakami
Hideaki Yamabe
Hiroshi Osawa
Ken Okumura
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2013
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/1471-2369-14-73

Other articles of this Issue 1/2013

BMC Nephrology 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.